The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - ACT Genomics; AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - ACT Genomics; AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Roche
Research Funding - ACT Genomics; Eisai; Pfizer; Taiho Pharmaceutical
Clinical efficacy and molecular effects of lenvatinib (Len) and letrozole (Let) in hormone receptor-positive (HR+) metastatic breast cancer (MBC).
 
Joline Si Jing Lim
Consulting or Advisory Role - Novartis; Pfizer; Pfizer
Research Funding - Synthon (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; Novartis; Pfizer
 
Andrea Wong
Travel, Accommodations, Expenses - Eisai
 
Samuel Guan Wei Ow
Honoraria - AstraZeneca; Lilly; Pfizer
 
Natalie Ngoi
Honoraria - Johnson & Johnson
Travel, Accommodations, Expenses - AstraZeneca
 
Yvonne Li'en Ang
Travel, Accommodations, Expenses - Boehringer Ingelheim Seiyaku
 
Gloria Chan
No Relationships to Disclose
 
Lim Siew Eng
No Relationships to Disclose
 
Wan Qin Chong
No Relationships to Disclose
 
Joan Choo
No Relationships to Disclose
 
Matilda Lee
No Relationships to Disclose
 
Hon Lyn Tan
No Relationships to Disclose
 
Yi-hua Jan
Employment - ACT Genomics
 
Kien Thiam Tan
Employment - ACT Genomics
Stock and Other Ownership Interests - ACT Genomics
 
Raghav Sundar
Honoraria - Bristol-Myers Squibb; Lilly; MSD; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Merck; Taiho Pharmaceutical
Research Funding - MSD; Paxman
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Roche; Taiho Pharmaceutical
 
David Shao Peng Tan
Honoraria - AstraZeneca; Bayer; Foundation Medicine; Janssen; Merck; Roche; Tessa Therapeutics
Consulting or Advisory Role - AstraZeneca; Bayer; Merck; Roche
Speakers' Bureau - Roche
Research Funding - AstraZeneca; Bayer; Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Merck; Novartis; Roche
 
Ross A. Soo
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Takeda; Yuhan
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Taiho Pharmaceutical; Takeda; Yuhan
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Cheng Ean Chee
Consulting or Advisory Role - Bayer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Wei-Peng Yong
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Bristol-Myers Squibb; Ipsen; Novartis
Speakers' Bureau - Eisai; Lilly; Sanofi/Aventis; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Pfizer
 
Boon C. Goh
Stock and Other Ownership Interests - Blueprint Medicines; Mirati Therapeutics; Seagen
Honoraria - Bayer; Merck
Consulting or Advisory Role - AstraZeneca; Bayer Health; Merck
Research Funding - Bayer; Genentech; Merck
Patents, Royalties, Other Intellectual Property - Sengenics (patent pending)
 
Soo-Chin Lee
No Relationships to Disclose